Antibody-based targeting of alternatively spliced tissue factor: a new approach to impede the primary growth and spread of pancreatic ductal adenocarcinoma.

Oncotarget · 2016 · PMC5041902 · PMID 26967388

Europe PMC DOI

hedged sentence

0.0020

closest p · 0.0× alpha

0.0020

boldest claim

The sentences

highly significantp = 0.002actually significant

We previously reported that constitutive overexpression of asTF in PT45.P1 cells induces MAPK and Akt phosphorylation [ 7 ]; in this study, MAPK p42/44 phosphorylation levels were unaffected by RabMab1 treatment (data not shown), yet a highly significant decrease in pAKT-T308 was observed ( p = 0.002), while the levels of pAKT-S473 were unaffected (Figure 5C ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.